# Ropiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery

> **NCT07131657** · PHASE2 · COMPLETED · sponsor: **PHARMAFINA** · enrollment: 40 (actual)

## Conditions studied

- Nerve Block
- Upper Extremity Surgery

## Interventions

- **DRUG:** Ropivacaine + Clonidine + Betamethasone
- **DRUG:** Ropivacaine + Clonidine + Betamethasone
- **DRUG:** Ropivacaine + Clonidine + Betamethasone

## Key facts

- **NCT ID:** NCT07131657
- **Lead sponsor:** PHARMAFINA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-02
- **Primary completion:** 2025-12-03
- **Final completion:** 2025-12-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07131657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07131657, "Ropiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT07131657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*